Causality of visceral adipose tissue on chronic kidney disease and renal function measure indicators, and mediation role of hypertension: Mendelian randomization study
Obesity Reviews · 2025
DOI: 10.1111/obr.13845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2025. Verfasst von Teng-Yu Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Glomerular Filtration Rate, Hypertension, Intra-Abdominal Fat. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Although chronic kidney disease (CKD) is associated with obesity, few studies have used visceral adipose tissue (VAT) as an indicator to investigate its causal effect on CKD. Therefore, Mendelian randomization (MR) was employed to study the causal effects of VAT on CKD and its potential mediation by hypertension. Genome‐wide association study (GWAS) statistics on VAT exposure were obtained from the UK Biobank, while GWAS datasets of CKD outcomes were obtained from CKDGen and FinnGen (validation study). Furthermore, VAT was considered the exposure, with the estimated glomerular filtration rate based on creatinine (eGFR (crea)), estimated glomerular filtration rate based on cystatin C (eGFR(cys)), and blood urea nitrogen (BUN) employed to assess the causal effect of VAT on kidney test indicators. Lastly, a two‐step MR method was used to study the mediating role of hypertension in the pathogenesis of VAT among patients with CKD. VAT exhibited a positive causal association with CKD, irrespective of whether the GWAS datasets from CKDGen (odds ratio [OR] = 1.18, 95% CI: 1.08 to 1.29, P = 1.433140e−04) or FinnGen (1.47, 1.30 to 1.67, p = 2.500000e−09). VAT was not causally associated with eGFR (crea) (1.00, 0.99 to 1.00, p = 0.53), was negatively associated with eGFR (cys) (0.95, 0.93 to 0.97, P = 5.070000e−10), and was positively associated with BUN (1.02,1.01 to 1.02, P = 7.824860e−04). The mediating effect of VAT on CKD via hypertension was 45.8% (95% CI: 26.4 65.1). VAT has a positive causal effect on CKD, with hypertension playing a significant role. However, the effects of VAT on renal function indicators require further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Chao Zhang
Zitieren
APA
Gao, T. Y., Wang, J. C., Zhao, Q. J., Zhou, X. N., Jiang, Y. T., Ren, L., & Zhang, C. (2025). Causality of visceral adipose tissue on chronic kidney disease and renal function measure indicators, and mediation role of hypertension: Mendelian randomization study. Obesity Reviews. https://doi.org/10.1111/obr.13845
Vancouver
Gao TY, Wang JC, Zhao QJ, Zhou XN, Jiang YT, Ren L, et al. Causality of visceral adipose tissue on chronic kidney disease and renal function measure indicators, and mediation role of hypertension: Mendelian randomization study. Obesity Reviews. 2025. doi:10.1111/obr.13845
BibTeX
@article{Gao2025,
author = {Gao, Teng-Yu and Wang, Jun-Chi and Zhao, Qi-Jian and Zhou, Xiang-Ning and Jiang, Yu-Ting and Ren, Lian and Zhang, Chao},
title = {Causality of visceral adipose tissue on chronic kidney disease and renal function measure indicators, and mediation role of hypertension: Mendelian randomization study},
journal = {Obesity Reviews},
year = {2025},
doi = {10.1111/obr.13845}
}
EUVIMED